China · Delayed Price · Currency is CNY ChengDa Pharmaceuticals Statistics
Total Valuation
SHE:301201 has a market cap or net worth of CNY 6.25 billion. The enterprise value is 5.34 billion.
| Market Cap | 6.25B |
| Enterprise Value | 5.34B |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
SHE:301201 has 151.47 million shares outstanding. The number of shares has decreased by -0.19% in one year.
| Current Share Class | 151.47M |
| Shares Outstanding | 151.47M |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 40.64% |
| Owned by Institutions (%) | 0.06% |
| Float | 71.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.63 |
| PB Ratio | 2.97 |
| P/TBV Ratio | 3.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 137.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.50, with an EV/FCF ratio of -423.17.
| EV / Earnings | -1,516.14 |
| EV / Sales | 11.66 |
| EV / EBITDA | 51.50 |
| EV / EBIT | 220.36 |
| EV / FCF | -423.17 |
Financial Position
The company has a current ratio of 7.57, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.57 |
| Quick Ratio | 6.44 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.57 |
| Debt / FCF | -4.68 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.17% and return on invested capital (ROIC) is 2.06%.
| Return on Equity (ROE) | -0.17% |
| Return on Assets (ROA) | 0.64% |
| Return on Invested Capital (ROIC) | 2.06% |
| Return on Capital Employed (ROCE) | 1.12% |
| Weighted Average Cost of Capital (WACC) | 4.34% |
| Revenue Per Employee | 755,031 |
| Profits Per Employee | -5,805 |
| Employee Count | 656 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, SHE:301201 has paid 1.24 million in taxes.
| Income Tax | 1.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +107.08% in the last 52 weeks. The beta is 0.02, so SHE:301201's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | +107.08% |
| 50-Day Moving Average | 44.50 |
| 200-Day Moving Average | 37.52 |
| Relative Strength Index (RSI) | 42.19 |
| Average Volume (20 Days) | 13,956,674 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301201 had revenue of CNY 458.30 million and -3.52 million in losses. Loss per share was -0.02.
| Revenue | 458.30M |
| Gross Profit | 185.31M |
| Operating Income | 24.25M |
| Pretax Income | -2.37M |
| Net Income | -3.52M |
| EBITDA | 103.74M |
| EBIT | 24.25M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 964.14 million in cash and 59.11 million in debt, with a net cash position of 905.02 million or 5.97 per share.
| Cash & Cash Equivalents | 964.14M |
| Total Debt | 59.11M |
| Net Cash | 905.02M |
| Net Cash Per Share | 5.97 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 13.87 |
| Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was 45.57 million and capital expenditures -58.19 million, giving a free cash flow of -12.63 million.
| Operating Cash Flow | 45.57M |
| Capital Expenditures | -58.19M |
| Depreciation & Amortization | 79.49M |
| Net Borrowing | -29.13M |
| Free Cash Flow | -12.63M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 40.43%, with operating and profit margins of 5.29% and -0.77%.
| Gross Margin | 40.43% |
| Operating Margin | 5.29% |
| Pretax Margin | -0.52% |
| Profit Margin | -0.77% |
| EBITDA Margin | 22.63% |
| EBIT Margin | 5.29% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.19% |
| Shareholder Yield | 0.69% |
| Earnings Yield | -0.06% |
| FCF Yield | -0.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jul 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |